Autor: Clinical genetics
-
‘Average’ human genome described for first time, with implications for disease risk
A new study has characterized the «average» human genome, providing key information on normal human genetic variation and genetic disease risk. The researchers conclude that everyone—regardless of their current health status—could potentially be told t…
-
‘Average’ human genome described for first time, with implications for disease risk
A new study has characterized the «average» human genome, providing key information on normal human genetic variation and genetic disease risk. The researchers conclude that everyone—regardless of their current health status—could potentially be told t…
-
Personalized medicine breakthrough for childhood leukemia
Researchers from Newcastle University and Great Ormond Street Hospital have identified new predictors of relapse in children and young people with acute lymphoblastic leukemia (ALL) treated with the immunotherapy drug blinatumomab, as part of a U.K.-wi…
-
Personalized medicine breakthrough for childhood leukemia
Researchers from Newcastle University and Great Ormond Street Hospital have identified new predictors of relapse in children and young people with acute lymphoblastic leukemia (ALL) treated with the immunotherapy drug blinatumomab, as part of a U.K.-wi…
-
Pancreatic cancer study highlights body’s natural molecules as potential treatment tools
Pancreatic cancer cells are remarkably good at doing one thing: growing. But new Texas A&M research suggests that two tiny molecules already present in the body may help slow them down.
-
Pancreatic cancer study highlights body’s natural molecules as potential treatment tools
Pancreatic cancer cells are remarkably good at doing one thing: growing. But new Texas A&M research suggests that two tiny molecules already present in the body may help slow them down.
-
Experimental treatment selectively reduces harmful protein in lab models of rare inherited brain disorder
Researchers from DZNE and the Hertie Institute for Clinical Brain Research (HIH) at the University of Tübingen, together with experts from Bonn, London and Portugal, have developed and successfully tested in human neurons cultured in the lab a new appr…
-
Experimental treatment selectively reduces harmful protein in lab models of rare inherited brain disorder
Researchers from DZNE and the Hertie Institute for Clinical Brain Research (HIH) at the University of Tübingen, together with experts from Bonn, London and Portugal, have developed and successfully tested in human neurons cultured in the lab a new appr…
-
Reducing nuclear damage improves heart function and survival in mice
Reducing damage to the nuclei of heart muscle cells improved heart function and extended survival in mice with a form of inherited heart disease, according to a new study led by Cornell researchers. The findings point to new approaches for understandin…
-
Reducing nuclear damage improves heart function and survival in mice
Reducing damage to the nuclei of heart muscle cells improved heart function and extended survival in mice with a form of inherited heart disease, according to a new study led by Cornell researchers. The findings point to new approaches for understandin…